TY  - JOUR

T1  - Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2026.44.16_suppl.4504

PY  - 2026/05/27

AU  - James ND

AU  - van de Wiel J

AU  - De Santis M

AU  - Din OS

AU  - Ford D

AU  - Hafeez S

AU  - Huddart RA

AU  - Hughes A

AU  - Iddenden J

AU  - Mir R

AU  - Vassallo - Bonner C et al

ED  - 

DO  - DOI: 10.1200/jco.2026.44.16_suppl.4504

PB  - American Society of Clinical Oncology (ASCO)

VL  - 44

IS  - 16_suppl

SP  - 4504

EP  - 4504

Y2  - 2026/06/23

ER  -